| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 193,895 | 261,322 | 158,120 | 199,172 | | Cost of Revenue | 58,809 | (47,088) | 53,856 | 50,271 | | | Gross Profit | 135,086 | 308,410 | 104,264 | 148,901 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,873 | 141,135 | 31,002 | 25,690 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 56,140 | 51,636 | 53,246 | 50,747 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 63,073 | 115,639 | 20,016 | 72,464 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,575 | (136,757) | 75,792 | 59,327 | | Earnings Before Interest And Taxes | 66,779 | 83,069 | 68,981 | 84,072 | | Interest Expense | 46,516 | 52,255 | 52,701 | 53,637 | | Income Before Tax | 20,263 | 30,814 | 16,280 | 30,435 | | Income Tax Expense | (1,653) | (17,065) | 12,335 | (1,138) | | Minority Interest |
-
| (495) | (11,559) | (6,136) | | | | Net Income From Continuing Ops | 41,427 | (62,611) | 97,682 | 93,646 | | | Non-recurring Events | | Discontinued Operations | 365 | 11,081 | 9,127 | 728 | | Extraordinary Items |
-
| 7 | 1,775 |
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 41,792 | (51,523) | 108,584 | 94,374 | | Preferred Stock And Other Adjustments | (15,190) | (11,822) | (11,822) | (11,822) | | | Net Income Applicable To Common Shares | $26,602 | ($63,345) | $96,762 | $82,552 |
|
0.45% Nasdaq 
0.20%
Income Statement
